Vometa

Indonesia • Dexa Medica

Indication

Symptomatic treatment of dyspeptic syndrome that may be associated with delayed gastric emptying, gastroesophageal reflux and esophagitis

  • Epigastric sense of fullness, feeling of fullness abdominal distension
  • Bloating, burping
  • Nausea and vomiting
  • Heartburn with or without regurgitation of stomach contents to mouth

Nausea, vomiting, burping due to various causes

  • Gastrointestinal intolerance due to anticancer chemotherapy, digitalis, levodopa and others including radiotherapy
  • Abdominal organs, gastrointestinal hepatobiliary, peritoneal and renal pathology
  • Vometa is not recommended for pediatrics unless to prevent nausea and vomiting associated with chemotherapy or cancer radiotherapy

Composition

Each ml contains domperidone 5 mg

Package

1 bottle of 10 ml

Dosage Forms

Drops

ATC Classification

A03F

Warning

Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Safe if Prescribed
This item is safe for use while operating heavy machinery.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Caution
This item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Dosage

0 to 18 Years Old

Children (nausea and vomiting related to chemotherapy and radiotherapy):
2.5 mg per 10 kg body weight, 3-4 times daily before meals and before bedtime.

Use in infants/pediatric:
The dose should be determined accurately and followed strictly in neonates, infants and children.

18 Years Old and Above

The dose should be the lowest effective dose for the individual situation (typically 30 mg/day) and the dose may be increased, to a maximum daily oral dose of 40 mg/day.

Chronic dyspepsia:
10 mg, 3 times daily, 15-30 minutes before meals and before bedtime.

Nausea and vomiting:
10 mg, 3-4 times daily before meals and before bedtime.

Use in Patient with Renal Impairment

Since very little unchanged drug is excreted via the kidneys, dose modification in patients with renal insufficiency is not needed. Therefore, on repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced. Such patients on prolonged therapy should be reviewed regularly.